1. ¹⁸FDG-PET imaging and histopathology in neuroleukemiosis with acute myeloid leukemia

   • Yusuke Kiyoki
   • Ryota Matsuoka
   • Hidekazu Nishikii

   Images in Hematology 31 August 2020 Pages: 433 - 434

   

2. Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry

   • Aya Nakaya
   • Takae Kohara
   • Kansai Myeloma Forum Investigators

   Rapid Communication 21 September 2020 Pages: 435 - 438

   

3. JSH practical guidelines for hematological malignancies, 2018: I. leukemia—3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL)

   • Yoshihiro Hatta
   • Fumihiko Hayakawa
   • Etsuko Yamazaki

   Guideline 18 August 2020 Pages: 439 - 458

   

4. Cutaneous manifestations of B-cell chronic lymphocytic leukemia

   • Elena A. Morozova
   • Olga Yu. Olisova
   • Eugene A. Nikitin

   Review Article 05 September 2020 Pages: 459 - 465

   

5. Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients

   • Ken Ishiyama
   • Shinji Nakao
   • Shinichiro Okamoto

   Original Article 31 August 2020 Pages: 466 - 476

   

6. New insights on patient-related risk factors for venous thromboembolism in patients with solid organ cancers

   • Aditya Kotecha
   • Deepa Raghavan
   • Camelia Arsene

   Original Article 06 July 2020 Pages: 477 - 486

7. Acute myeloid leukemia during pregnancy: a single institutional experience with 17 patients and literature review

   • Yi-Wei Li
   • Yang-Feng Xu
   • Can Chen

   Original Article 18 July 2020 Pages: 487 - 495

8. Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma

   • Syahrul Chilmi
   • Shingo Nakahata
   • Kazuhiro Morishita

   Original Article 12 July 2020 Pages: 496 - 503

   

9. Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphoma

   • Koji Izutsu
   • Koji Kato
   • Koichi Akashi

   Original Article 01 July 2020 Pages: 504 - 509

10. Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies

    • Naoyuki Uchida
    • Kana Matsumoto
    • for the Japan Study Group for Cell Therapy, Transplantation (JSCT)

    Original Article 12 July 2020 Pages: 510 - 523

    

11. Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group

    • Sachie Kasai
    • Hidehiro Itonaga
    • Yasushi Miyazaki

    Original Article 25 June 2020 Pages: 524 - 534

    

12. Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan

    • Akihiko Yokohama
    • Yoshiki Okuyama
    • Kazuo Muroi

    Original Article 18 July 2020 Pages: 535 - 543

    

13. Potential role of Howell−Jolly bodies in identifying functional hyposplenism: a prospective single-institute study

    • Yuya Nakagami
    • Kaori Uchino
    • Akiyoshi Takami

    Original Article 23 June 2020 Pages: 544 - 552

    

14. Changes of hematological and immunological parameters in COVID-19 patients

    • Xiaohong Yuan
    • Wanling Huang
    • Jianda Hu

    Original Article 12 July 2020 Pages: 553 - 559

15. Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan

    • Tomomi Hayase
    • Shiori Saito
    • Akira Morimoto

    Original Article 11 July 2020 Pages: 560 - 567

    

16. Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children

    • Ang Wei
    • Honghao Ma
    • Tianyou Wang

    Original Article 14 July 2020 Pages: 568 - 576

    

17. Nausea and vomiting during post-transplantation cyclophosphamide administration

    • Toshihisa Nakashima
    • Yoshihiro Inamoto
    • Masakazu Yamaguchi

    Original Article 12 July 2020 Pages: 577 - 583

    

18. Pathological findings suggesting vascular endothelial damage in multiple organs in chronic myelogenous leukemia patients on long-term tyrosine kinase inhibitor therapy

    • Yoshinobu Seki
    • Ouki Nagano
    • Go Hasegawa

    Case Report 18 June 2020 Pages: 584 - 591

    

19. Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus

    • Satoshi Ichikawa
    • Noriko Fukuhara
    • Hideo Harigae

    Case Report 08 June 2020 Pages: 592 - 596

    

20. Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab

    • Ciprian Tomuleasa
    • Sabina Iluta
    • Bobe Petrushev

    Letter to the Editor 04 September 2020 Pages: 597 - 598

    

21. Correction to: Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells

    • Aya Fujishiro
    • Masaki Iwasa
    • Yasuo Miura

    Correction 15 September 2020 Pages: 599 - 602